Robert Buchberger M.D.

Robert Buchberger MD PhD has extensive experience in the field of pharmacovigilance and risk management. Robert began their career in 1995 as a Clinical Psychiatrist at the University of Hamburg. From 1999 to 2010, they held various roles at Solvay Pharmaceuticals, including Global Head Pharmacovigilance Operations and Deputy EU QPPV. In 2010, they joined Abbott as Senior Vice President Global Pharmacovigilance & Risk Management, EU QPPV. Robert then moved on to Boehringer Ingelheim in 2011, where they are currently serving as Corporate Senior Vice President and Global Head of Patient Safety & Pharmacovigilance.

Robert Buchberger MD PhD completed their education at Ludwig-Maximilians-Universität München where they earned their Medical Doctor degree from 1987 to 1993. In 2008, they also attended the London Business School for a Senior Executive Programme.